These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 9034168

  • 41. Detection of a tandem BRCT in Nbs1 and Xrs2 with functional implications in the DNA damage response.
    Becker E, Meyer V, Madaoui H, Guerois R.
    Bioinformatics; 2006 Jun 01; 22(11):1289-92. PubMed ID: 16522671
    [Abstract] [Full Text] [Related]

  • 42. Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites.
    Xu C, Wu L, Cui G, Botuyan MV, Chen J, Mer G.
    J Mol Biol; 2008 Aug 29; 381(2):361-72. PubMed ID: 18582474
    [Abstract] [Full Text] [Related]

  • 43. Solution structure and backbone dynamics of the human DNA ligase IIIalpha BRCT domain.
    Krishnan VV, Thornton KH, Thelen MP, Cosman M.
    Biochemistry; 2001 Nov 06; 40(44):13158-66. PubMed ID: 11683624
    [Abstract] [Full Text] [Related]

  • 44. Homo-oligomerization is the essential function of the tandem BRCT domains in the checkpoint protein Crb2.
    Du LL, Moser BA, Russell P.
    J Biol Chem; 2004 Sep 10; 279(37):38409-14. PubMed ID: 15229228
    [Abstract] [Full Text] [Related]

  • 45. BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220.
    Wada O, Oishi H, Takada I, Yanagisawa J, Yano T, Kato S.
    Oncogene; 2004 Aug 05; 23(35):6000-5. PubMed ID: 15208681
    [Abstract] [Full Text] [Related]

  • 46. NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain.
    Ozaki T, Nagase T, Ichimiya S, Seki N, Ohiri M, Nomura N, Takada N, Sakiyama S, Weber BL, Nakagawara A.
    DNA Cell Biol; 2000 Aug 05; 19(8):475-85. PubMed ID: 10975465
    [Abstract] [Full Text] [Related]

  • 47. Dictyostelium nucleomorphin is a member of the BRCT-domain family of cell cycle checkpoint proteins.
    Myre MA, O'Day DH.
    Biochim Biophys Acta; 2004 Nov 18; 1675(1-3):192-7. PubMed ID: 15535983
    [Abstract] [Full Text] [Related]

  • 48. Structure of the DNA-bound BRCA1 C-terminal region from human replication factor C p140 and model of the protein-DNA complex.
    Kobayashi M, Ab E, Bonvin AMJJ, Siegal G.
    J Biol Chem; 2010 Mar 26; 285(13):10087-10097. PubMed ID: 20081198
    [Abstract] [Full Text] [Related]

  • 49. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV, Nominé Y, Yu X, Juranic N, Macura S, Chen J, Mer G.
    Structure; 2004 Jul 26; 12(7):1137-46. PubMed ID: 15242590
    [Abstract] [Full Text] [Related]

  • 50. Crystal structure of the BARD1 BRCT domains.
    Birrane G, Varma AK, Soni A, Ladias JA.
    Biochemistry; 2007 Jul 03; 46(26):7706-12. PubMed ID: 17550235
    [Abstract] [Full Text] [Related]

  • 51. The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response.
    Li M, Lu LY, Yang CY, Wang S, Yu X.
    Genes Dev; 2013 Aug 15; 27(16):1752-68. PubMed ID: 23964092
    [Abstract] [Full Text] [Related]

  • 52. Characterization of the DNA binding and structural properties of the BRCT region of human replication factor C p140 subunit.
    Kobayashi M, Figaroa F, Meeuwenoord N, Jansen LE, Siegal G.
    J Biol Chem; 2006 Feb 17; 281(7):4308-17. PubMed ID: 16361700
    [Abstract] [Full Text] [Related]

  • 53. Discovery of cell-permeable inhibitors that target the BRCT domain of BRCA1 protein by using a small-molecule microarray.
    Na Z, Pan S, Uttamchandani M, Yao SQ.
    Angew Chem Int Ed Engl; 2014 Aug 04; 53(32):8421-6. PubMed ID: 24961672
    [Abstract] [Full Text] [Related]

  • 54. "Similarity trap" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains.
    Liu J, Pan Y, Ma B, Nussinov R.
    Structure; 2006 Dec 04; 14(12):1811-21. PubMed ID: 17161371
    [Abstract] [Full Text] [Related]

  • 55. Dampening DNA damage checkpoint signalling via coordinated BRCT domain interactions.
    Cussiol JR, Jablonowski CM, Yimit A, Brown GW, Smolka MB.
    EMBO J; 2015 Jun 12; 34(12):1704-17. PubMed ID: 25896509
    [Abstract] [Full Text] [Related]

  • 56. Expression, purification, and biophysical characterization of the BRCT domain of human DNA ligase IIIalpha.
    Thornton KH, Krishnan VV, West MG, Popham J, Ramirez M, Thelen MP, Cosman M.
    Protein Expr Purif; 2001 Apr 12; 21(3):401-11. PubMed ID: 11281714
    [Abstract] [Full Text] [Related]

  • 57. Mapping and conformational characterization of the DNA-binding region of the breast cancer susceptibility protein BRCA1.
    Naseem R, Sturdy A, Finch D, Jowitt T, Webb M.
    Biochem J; 2006 May 01; 395(3):529-35. PubMed ID: 16460311
    [Abstract] [Full Text] [Related]

  • 58. Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain.
    Hu YF, Miyake T, Ye Q, Li R.
    J Biol Chem; 2000 Dec 29; 275(52):40910-5. PubMed ID: 11067843
    [Abstract] [Full Text] [Related]

  • 59. "DNA Binding Region" of BRCA1 Affects Genetic Stability through modulating the Intra-S-Phase Checkpoint.
    Masuda T, Xu X, Dimitriadis EK, Lahusen T, Deng CX.
    Int J Biol Sci; 2016 Dec 29; 12(2):133-43. PubMed ID: 26884712
    [Abstract] [Full Text] [Related]

  • 60. Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif.
    Wu Q, Jubb H, Blundell TL.
    Prog Biophys Mol Biol; 2015 Mar 29; 117(2-3):143-148. PubMed ID: 25701377
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.